We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Second Opinions Reveal Extent of Diagnostic Error

By HospiMedica International staff writers
Posted on 20 Apr 2017
A new study reports that as many as 88% of patients referred for a second opinion receive a refined diagnosis that can change their care plan, and potentially their lives.

Researchers at the Mayo Clinic conducted a retrospective study of 286 patients referred for additional consultation by physicians, physician assistants, and nurse practitioners from primary care practices from January 1, 2009 to December 31, 2010. More...
Patients' referral and final diagnoses were compared and classified into one of three categories: equal referral diagnosis and final diagnosis, referral diagnosis better defined or refined, and referral diagnosis distinctly different from final diagnosis.

The results revealed that in 12% of cases, referral diagnoses were the same as the final diagnoses. Final diagnoses were better defined or more refined in 66% of the cases; but in 21% of cases, the final diagnoses were distinctly different than the referral diagnoses. The researchers also identified costs associated with second opinions, and found that total diagnostic costs for cases resulting in a different final diagnosis were significantly higher than those for confirmed or refined diagnoses. The study was published on April 4, 2017, in Journal of Evaluation in Clinical Practice.

“Effective and efficient treatment depends on the right diagnosis. Referrals to advanced specialty care for undifferentiated problems are an essential component of patient care,” said lead author health care policy researcher James Naessens, ScD. “Knowing that more than one out of every five referral patients may be completely [and] incorrectly diagnosed is troubling, not only because of the safety risks for these patients prior to correct diagnosis, but also because of the patients we assume are not being referred at all.”

Diagnostic uncertainty is often encountered in a medical practice. Patients with ambiguous, uncertain, and undiagnosed problems are frequently referred for second opinions. But in order to reduce costs, health insurers often limit access to care outside their own network, effectively limiting referrals. In addition, primary care providers may be more confident in their diagnostic expertise than warranted in a particular case, or patients may lack the knowledge or assertiveness to request a referral.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.